Depressing results from Prozac study
In 2005, Zoloft sales topped $3 billion. In 2006, Prozac sales reached almost half a billion dollars. Other SSRI drugs include Celexa, Lexapro, and Paxil as well as newer drugs such as Effexor, which works on both serotonin and norepinephrine.
To the degree that an antidepressant's effectiveness is aided by the patient's belief that it works, studies such as this serve to undermine that placebo effect. Given the strong motivation for drug companies to sell such products, the desperate need that the clinically depressed have, and the desire of physicians to provide relief, I can see how we might have all willingly embraced what now seems to have been a mass delusion: That these drugs help patients.
Man, that makes me blue.